|
ZNF583 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71640479607049E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.96864746726533E-12 |
| Normal-vs-Stage2 |
5.86399995228248E-09 |
| Normal-vs-Stage3 |
1.63313806922361E-12 |
| Normal-vs-Stage4 |
4.40814051927418E-12 |
| Stage1-vs-Stage2 |
3.024400E-01 |
| Stage1-vs-Stage3 |
7.311600E-02 |
| Stage1-vs-Stage4 |
1.446230E-01 |
| Stage2-vs-Stage3 |
4.342300E-02 |
| Stage2-vs-Stage4 |
6.630300E-02 |
| Stage3-vs-Stage4 |
7.526200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65767399806782E-12 |
| Normal-vs-AfricanAmerican |
9.21018816768537E-12 |
| Normal-vs-Asian |
3.37979644271513E-11 |
| Caucasian-vs-AfricanAmerican |
8.093000E-01 |
| Caucasian-vs-Asian |
3.215200E-01 |
| AfricanAmerican-vs-Asian |
3.218800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27675647831893E-14 |
| Normal-vs-Female |
1.6885381981524E-12 |
| Male-vs-Female |
6.095600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.04836148043341E-13 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64812608005604E-12 |
| Normal-vs-Age(81-100Yrs) |
5.338800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.131600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.012000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.102800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.833400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.972000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.784800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.41869999999533E-05 |
| Classical-VS-Follicular |
1.992220E-01 |
| Classical-VS-Other |
4.136200E-01 |
| Classical-VS-Normal |
9.47475431445355E-12 |
| Tall-VS-Follicular |
1.375550E-02 |
| Tall-VS-Other |
3.267800E-01 |
| Tall-VS-Normal |
3.33066907387547E-16 |
| Follicular-VS-Other |
7.406200E-01 |
| Follicular-VS-Normal |
1.67499347725197E-12 |
| Other-VS-Normal |
3.414300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.44089209850063E-16 |
| N0-vs-N1 |
7.219700E-03 |
|
|
